LinkinVax raised €3.8M in a Seed round in Feb 2022. The company is based in Paris, France. Investors in the round: Alain Tingaud, André - Jacques Auberton - Hervé, Geoffrey Duyk and 3 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
